img

Global Injectable Drug Delivery Formulation Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 264 | Industry : Pharma & Healthcare

Publisher : QMR | Format : PDF

Global Injectable Drug Delivery Formulation Sales Market Report 2024

The global Injectable Drug Delivery Formulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations


Segment by Application


Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others

The Injectable Drug Delivery Formulation market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Injectable Drug Delivery Formulation market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)

Table of Content

1 Injectable Drug Delivery Formulation Market Overview
1.1 Injectable Drug Delivery Formulation Product Scope
1.2 Injectable Drug Delivery Formulation Segment by Type
1.2.1 Global Injectable Drug Delivery Formulation Sales by Type (2016 & 2021 & 2027)
1.2.2 Conventional Drug Delivery Formulations
1.2.3 Novel Drug Delivery Formulations
1.2.4 Long-acting Formulations
1.3 Injectable Drug Delivery Formulation Segment by Application
1.3.1 Global Injectable Drug Delivery Formulation Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Autoimmune Diseases
1.3.3 Hormonal Disorders
1.3.4 Oncology
1.3.5 Orphan Diseases
1.3.6 Others
1.4 Injectable Drug Delivery Formulation Market Estimates and Forecasts (2016-2027)
1.4.1 Global Injectable Drug Delivery Formulation Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Injectable Drug Delivery Formulation Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Injectable Drug Delivery Formulation Price Trends (2016-2027)

2 Injectable Drug Delivery Formulation Estimates and Forecasts by Region
2.1 Global Injectable Drug Delivery Formulation Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Injectable Drug Delivery Formulation Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2021)
2.2.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Region (2016-2021)
2.3 Global Injectable Drug Delivery Formulation Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Injectable Drug Delivery Formulation Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)
2.4.2 Europe Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)
2.4.3 China Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)
2.4.4 Japan Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)
2.4.6 India Injectable Drug Delivery Formulation Estimates and Projections (2016-2027)

3 Global Injectable Drug Delivery Formulation Competition Landscape by Players
3.1 Global Top Injectable Drug Delivery Formulation Players by Sales (2016-2021)
3.2 Global Top Injectable Drug Delivery Formulation Players by Revenue (2016-2021)
3.3 Global Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drug Delivery Formulation as of 2020)
3.4 Global Injectable Drug Delivery Formulation Average Price by Company (2016-2021)
3.5 Manufacturers Injectable Drug Delivery Formulation Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Injectable Drug Delivery Formulation Market Size by Type
4.1 Global Injectable Drug Delivery Formulation Historic Market Review by Type (2016-2021)
4.1.1 Global Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
4.1.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Type (2016-2021)
4.1.3 Global Injectable Drug Delivery Formulation Price by Type (2016-2021)
4.2 Global Injectable Drug Delivery Formulation Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Type (2022-2027)
4.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Type (2022-2027)
4.2.3 Global Injectable Drug Delivery Formulation Price Forecast by Type (2022-2027)

5 Global Injectable Drug Delivery Formulation Market Size by Application
5.1 Global Injectable Drug Delivery Formulation Historic Market Review by Application (2016-2021)
5.1.1 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
5.1.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2016-2021)
5.1.3 Global Injectable Drug Delivery Formulation Price by Application (2016-2021)
5.2 Global Injectable Drug Delivery Formulation Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Injectable Drug Delivery Formulation Sales Forecast by Application (2022-2027)
5.2.2 Global Injectable Drug Delivery Formulation Revenue Forecast by Application (2022-2027)
5.2.3 Global Injectable Drug Delivery Formulation Price Forecast by Application (2022-2027)

6 North America Injectable Drug Delivery Formulation Market Facts & Figures
6.1 North America Injectable Drug Delivery Formulation Sales by Company
6.1.1 North America Injectable Drug Delivery Formulation Sales by Company (2016-2021)
6.1.2 North America Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
6.2 North America Injectable Drug Delivery Formulation Sales Breakdown by Type
6.2.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
6.2.2 North America Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
6.3 North America Injectable Drug Delivery Formulation Sales Breakdown by Application
6.3.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Application (2016-2021)
6.3.2 North America Injectable Drug Delivery Formulation Sales Breakdown by Application (2022-2027)

7 Europe Injectable Drug Delivery Formulation Market Facts & Figures
7.1 Europe Injectable Drug Delivery Formulation Sales by Company
7.1.1 Europe Injectable Drug Delivery Formulation Sales by Company (2016-2021)
7.1.2 Europe Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
7.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Type
7.2.1 Europe Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
7.2.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
7.3 Europe Injectable Drug Delivery Formulation Sales Breakdown by Application
7.3.1 Europe 121 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 121 Sales Breakdown by Application (2022-2027)

8 China Injectable Drug Delivery Formulation Market Facts & Figures
8.1 China Injectable Drug Delivery Formulation Sales by Company
8.1.1 China Injectable Drug Delivery Formulation Sales by Company (2016-2021)
8.1.2 China Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
8.2 China Injectable Drug Delivery Formulation Sales Breakdown by Type
8.2.1 China Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
8.2.2 China Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
8.3 China Injectable Drug Delivery Formulation Sales Breakdown by Application
8.3.1 China 144 Sales Breakdown by Application (2016-2021)
8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Injectable Drug Delivery Formulation Market Facts & Figures
9.1 Japan Injectable Drug Delivery Formulation Sales by Company
9.1.1 Japan Injectable Drug Delivery Formulation Sales by Company (2016-2021)
9.1.2 Japan Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
9.2 Japan Injectable Drug Delivery Formulation Sales Breakdown by Type
9.2.1 Japan Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
9.2.2 Japan Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
9.3 Japan Injectable Drug Delivery Formulation Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Injectable Drug Delivery Formulation Market Facts & Figures
10.1 Southeast Asia Injectable Drug Delivery Formulation Sales by Company
10.1.1 Southeast Asia Injectable Drug Delivery Formulation Sales by Company (2016-2021)
10.1.2 Southeast Asia Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
10.2 Southeast Asia Injectable Drug Delivery Formulation Sales Breakdown by Type
10.2.1 Southeast Asia Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Injectable Drug Delivery Formulation Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Injectable Drug Delivery Formulation Market Facts & Figures
11.1 India Injectable Drug Delivery Formulation Sales by Company
11.1.1 India Injectable Drug Delivery Formulation Sales by Company (2016-2021)
11.1.2 India Injectable Drug Delivery Formulation Revenue by Company (2016-2021)
11.2 India Injectable Drug Delivery Formulation Sales Breakdown by Type
11.2.1 India Injectable Drug Delivery Formulation Sales Breakdown by Type (2016-2021)
11.2.2 India Injectable Drug Delivery Formulation Sales Breakdown by Type (2022-2027)
11.3 India Injectable Drug Delivery Formulation Sales Breakdown by Application
11.3.1 India Injectable Drug Delivery Formulation Sales Breakdown by Application (2016-2021)
11.3.2 India Injectable Drug Delivery Formulation Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Injectable Drug Delivery Formulation Business
12.1 Becton, Dickinson and Company (US)
12.1.1 Becton, Dickinson and Company (US) Corporation Information
12.1.2 Becton, Dickinson and Company (US) Business Overview
12.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
12.1.5 Becton, Dickinson and Company (US) Recent Development
12.2 Baxter International Inc. (US)
12.2.1 Baxter International Inc. (US) Corporation Information
12.2.2 Baxter International Inc. (US) Business Overview
12.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
12.2.5 Baxter International Inc. (US) Recent Development
12.3 Gerresheimer AG (Germany)
12.3.1 Gerresheimer AG (Germany) Corporation Information
12.3.2 Gerresheimer AG (Germany) Business Overview
12.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
12.3.5 Gerresheimer AG (Germany) Recent Development
12.4 Pfizer, Inc. (US)
12.4.1 Pfizer, Inc. (US) Corporation Information
12.4.2 Pfizer, Inc. (US) Business Overview
12.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
12.4.5 Pfizer, Inc. (US) Recent Development
12.5 Schott AG (Germany)
12.5.1 Schott AG (Germany) Corporation Information
12.5.2 Schott AG (Germany) Business Overview
12.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
12.5.5 Schott AG (Germany) Recent Development
12.6 Sandoz (Germany)
12.6.1 Sandoz (Germany) Corporation Information
12.6.2 Sandoz (Germany) Business Overview
12.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
12.6.5 Sandoz (Germany) Recent Development
12.7 Teva Pharmaceutical Industries Ltd. (Israel)
12.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
12.8 Eli Lilly and Company (US)
12.8.1 Eli Lilly and Company (US) Corporation Information
12.8.2 Eli Lilly and Company (US) Business Overview
12.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
12.8.5 Eli Lilly and Company (US) Recent Development

13 Injectable Drug Delivery Formulation Manufacturing Cost Analysis
13.1 Injectable Drug Delivery Formulation Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Injectable Drug Delivery Formulation
13.4 Injectable Drug Delivery Formulation Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Injectable Drug Delivery Formulation Distributors List
14.3 Injectable Drug Delivery Formulation Customers

15 Market Dynamics
15.1 Injectable Drug Delivery Formulation Market Trends
15.2 Injectable Drug Delivery Formulation Drivers
15.3 Injectable Drug Delivery Formulation Market Challenges
15.4 Injectable Drug Delivery Formulation Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Injectable Drug Delivery Formulation Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Injectable Drug Delivery Formulation Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Injectable Drug Delivery Formulation Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Region (2016-2021)
Table 5. Global Injectable Drug Delivery Formulation Sales Market Share by Region (2016-2021)
Table 6. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Injectable Drug Delivery Formulation Revenue Share by Region (2016-2021)
Table 8. Global Injectable Drug Delivery Formulation Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Injectable Drug Delivery Formulation Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Injectable Drug Delivery Formulation Revenue Share Forecast by Region (2022-2027)
Table 12. Global Injectable Drug Delivery Formulation Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Injectable Drug Delivery Formulation Sales Share by Company (2016-2021)
Table 14. Global Injectable Drug Delivery Formulation Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Injectable Drug Delivery Formulation Revenue Share by Company (2016-2021)
Table 16. Global Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Drug Delivery Formulation as of 2020)
Table 17. Global Injectable Drug Delivery Formulation Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Injectable Drug Delivery Formulation Manufacturing Sites and Area Served
Table 19. Manufacturers Injectable Drug Delivery Formulation Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2016-2021)
Table 22. Global Injectable Drug Delivery Formulation Sales Share by Type (2016-2021)
Table 23. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Injectable Drug Delivery Formulation Sales Share by Type (2022-2027)
Table 26. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Injectable Drug Delivery Formulation Revenue Share by Type (2022-2027)
Table 28. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2016-2021)
Table 30. Global Injectable Drug Delivery Formulation Sales Share by Application (2016-2021)
Table 31. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Injectable Drug Delivery Formulation Sales (K Pcs) by Application (2022-2027)
Table 34. Global Injectable Drug Delivery Formulation Sales Share by Application (2022-2027)
Table 35. Global Injectable Drug Delivery Formulation Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Injectable Drug Delivery Formulation Revenue Share by Application (2022-2027)
Table 37. Global Injectable Drug Delivery Formulation Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 39. North America Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 40. North America Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 42. North America Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 44. North America Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 46. North America Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 48. North America Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 50. Europe Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 52. Europe Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 54. Europe Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 56. Europe Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 58. Europe Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 60. Europe Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 62. China Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 63. China Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 64. China Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 66. China Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 67. China Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 68. China Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 69. China Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 70. China Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 71. China Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 72. China Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 73. China Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 74. Japan Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 76. Japan Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 78. Japan Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 80. Japan Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 82. Japan Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 84. Japan Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 98. India Injectable Drug Delivery Formulation Sales (K Pcs) by Company (2016-2021)
Table 99. India Injectable Drug Delivery Formulation Sales Market Share by Company (2016-2021)
Table 100. India Injectable Drug Delivery Formulation Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Injectable Drug Delivery Formulation Revenue Market Share by Company (2016-2021)
Table 102. India Injectable Drug Delivery Formulation Sales by Type (2016-2021) & (K Pcs)
Table 103. India Injectable Drug Delivery Formulation Sales Market Share by Type (2016-2021)
Table 104. India Injectable Drug Delivery Formulation Sales by Type (2022-2027) & (K Pcs)
Table 105. India Injectable Drug Delivery Formulation Sales Market Share by Type (2022-2027)
Table 106. India Injectable Drug Delivery Formulation Sales by Application (2016-2021) & (K Pcs)
Table 107. India Injectable Drug Delivery Formulation Sales Market Share by Application (2016-2021)
Table 108. India Injectable Drug Delivery Formulation Sales by Application (2022-2027) & (K Pcs)
Table 109. India Injectable Drug Delivery Formulation Sales Market Share by Application (2022-2027)
Table 110. Becton, Dickinson and Company (US) Corporation Information
Table 111. Becton, Dickinson and Company (US) Description and Business Overview
Table 112. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product
Table 114. Becton, Dickinson and Company (US) Recent Development
Table 115. Baxter International Inc. (US) Corporation Information
Table 116. Baxter International Inc. (US) Description and Business Overview
Table 117. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product
Table 119. Baxter International Inc. (US) Recent Development
Table 120. Gerresheimer AG (Germany) Corporation Information
Table 121. Gerresheimer AG (Germany) Description and Business Overview
Table 122. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product
Table 124. Gerresheimer AG (Germany) Recent Development
Table 125. Pfizer, Inc. (US) Corporation Information
Table 126. Pfizer, Inc. (US) Description and Business Overview
Table 127. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product
Table 129. Pfizer, Inc. (US) Recent Development
Table 130. Schott AG (Germany) Corporation Information
Table 131. Schott AG (Germany) Description and Business Overview
Table 132. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Schott AG (Germany) Injectable Drug Delivery Formulation Product
Table 134. Schott AG (Germany) Recent Development
Table 135. Sandoz (Germany) Corporation Information
Table 136. Sandoz (Germany) Description and Business Overview
Table 137. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Sandoz (Germany) Injectable Drug Delivery Formulation Product
Table 139. Sandoz (Germany) Recent Development
Table 140. Teva Pharmaceutical Industries Ltd. (Israel) Corporation Information
Table 141. Teva Pharmaceutical Industries Ltd. (Israel) Description and Business Overview
Table 142. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product
Table 144. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 145. Eli Lilly and Company (US) Corporation Information
Table 146. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Eli Lilly and Company (US) Description and Business Overview
Table 148. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product
Table 149. Eli Lilly and Company (US) Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Injectable Drug Delivery Formulation Distributors List
Table 153. Injectable Drug Delivery Formulation Customers List
Table 154. Injectable Drug Delivery Formulation Market Trends
Table 155. Injectable Drug Delivery Formulation Market Drivers
Table 156. Injectable Drug Delivery Formulation Market Challenges
Table 157. Injectable Drug Delivery Formulation Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Drug Delivery Formulation Product Picture
Figure 2. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2021 & 2027
Figure 3. Conventional Drug Delivery Formulations Product Picture
Figure 4. Novel Drug Delivery Formulations Product Picture
Figure 5. Long-acting Formulations Product Picture
Figure 6. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2021 & 2027
Figure 7. Autoimmune Diseases Examples
Figure 8. Hormonal Disorders Examples
Figure 9. Oncology Examples
Figure 10. Orphan Diseases Examples
Figure 11. Others Examples
Figure 12. Global Injectable Drug Delivery Formulation Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Injectable Drug Delivery Formulation Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Injectable Drug Delivery Formulation Sales (K Pcs) Growth Rate (2016-2027)
Figure 15. Global Injectable Drug Delivery Formulation Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 16. Global Injectable Drug Delivery Formulation Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Injectable Drug Delivery Formulation Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Injectable Drug Delivery Formulation Sales (K Pcs) Growth Rate (2016-2027)
Figure 20. Europe Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Injectable Drug Delivery Formulation Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Injectable Drug Delivery Formulation Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Injectable Drug Delivery Formulation Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Injectable Drug Delivery Formulation Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Injectable Drug Delivery Formulation Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Injectable Drug Delivery Formulation Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Injectable Drug Delivery Formulation Players Market Share by Revenue in Injectable Drug Delivery Formulation: 2016 & 2020
Figure 31. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Injectable Drug Delivery Formulation Revenue Share by Type (2016-2021)
Figure 33. Global Injectable Drug Delivery Formulation Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Injectable Drug Delivery Formulation Revenue Share by Application (2016-2021)
Figure 35. Global Injectable Drug Delivery Formulation Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 37. North America Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 38. Europe Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 39. Europe Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 40. China Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 41. China Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 42. Japan Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 43. Japan Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 44. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 45. Southeast Asia Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 46. India Injectable Drug Delivery Formulation Sales Market Share by Type in 2020
Figure 47. India Injectable Drug Delivery Formulation Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Injectable Drug Delivery Formulation
Figure 50. Manufacturing Process Analysis of Injectable Drug Delivery Formulation
Figure 51. Injectable Drug Delivery Formulation Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed